Page 54 - Read Online

Cote et al. J Cancer Metastasis Treat 2022;8:36 https://dx.doi.org/10.20517/2394-4722.2022.41 Page 11 of 11

malignant mesothelioma. Sci Rep 2016;6:24578. DOI PubMed PMC
78. Lima AR, Santos L, Correia M, et al. Dynamin-related protein 1 at the crossroads of cancer. Genes (Basel) 2018;9:115. DOI
PubMed PMC
79. Qian W, Choi S, Gibson GA, Watkins SC, Bakkenist CJ, Van Houten B. Mitochondrial hyperfusion induced by loss of the fission
protein Drp1 causes ATM-dependent G2/M arrest and aneuploidy through DNA replication stress. J Cell Sci 2012;125:5745-57. DOI
PubMed PMC
80. Wang J, Mirzapoiazova T, Carol Tan YH, et al. Inhibiting crosstalk between MET signaling and mitochondrial dynamics and
morphology: a novel therapeutic approach for lung cancer and mesothelioma. Cancer Biol Ther 2018;19:1023-32. DOI PubMed
PMC
81. Grosso S, Marini A, Gyuraszova K, et al. The pathogenesis of mesothelioma is driven by a dysregulated translatome. Nat Commun
2021;12:4920. DOI PubMed PMC
82. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and
cardiovascular disease. N Engl J Med 1996;334:1150-5. DOI PubMed
83. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med
1994;330:1029-35. DOI PubMed
84. Tai DJ, Jin WS, Wu CS, et al. Changes in intracellular redox status influence multidrug resistance in gastric adenocarcinoma cells.
Exp Ther Med 2012;4:291-6. DOI PubMed PMC
85. Hwang IT, Chung YM, Kim JJ, et al. Drug resistance to 5-FU linked to reactive oxygen species modulator 1. Biochem Biophys Res
Commun 2007;359:304-10. DOI PubMed
86. Chen Q, Espey MG, Sun AY, et al. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen
peroxide in extracellular fluid in vivo. Proc Natl Acad Sci USA 2007;104:8749-54. DOI PubMed PMC
87. Alexander MS, Wilkes JG, Schroeder SR, et al. Pharmacologic ascorbate reduces radiation-induced normal tissue toxicity and
enhances tumor radiosensitization in pancreatic cancer. Cancer Res 2018;78:6838-51. DOI PubMed PMC
88. Mehdi Z, Petronek MS, Stolwijk JM, et al. Utilization of pharmacological ascorbate to enhance hydrogen peroxide-mediated
radiosensitivity in cancer therapy. Int J Mol Sci 2021;22:10880. DOI PubMed PMC
89. Beddowes E, Spicer J, Chan PY, et al. Phase 1 dose-escalation study of pegylated arginine deiminase, cisplatin, and pemetrexed in
patients with argininosuccinate synthetase 1-deficient thoracic cancers. J Clin Oncol 2017;35:1778-85. DOI PubMed PMC
90. Szlosarek PW, Luong P, Phillips MM, et al. Metabolic response to pegylated arginine deiminase in mesothelioma with promoter
methylation of argininosuccinate synthetase. J Clin Oncol 2013;31:e111-3. DOI PubMed
91. Kung HJ, Changou CA, Li CF, Ann DK. Chromatophagy: autophagy goes nuclear and captures broken chromatin during arginine-
starvation. Autophagy 2015;11:419-21. DOI PubMed PMC
92. Cheng CT, Qi Y, Wang YC, et al. Arginine starvation kills tumor cells through aspartate exhaustion and mitochondrial dysfunction.
Commun Biol 2018;1:178. DOI PubMed PMC
93. Szlosarek PW, Klabatsa A, Pallaska A, et al. In vivo loss of expression of argininosuccinate synthetase in malignant pleural
mesothelioma is a biomarker for susceptibility to arginine depletion. Clin Cancer Res 2006;12:7126-31. DOI PubMed
94. Kremer JC, Prudner BC, Lange SES, et al. Arginine deprivation inhibits the warburg effect and upregulates glutamine anaplerosis and
serine biosynthesis in ASS1-deficient cancers. Cell Rep 2017;18:991-1004. DOI PubMed PMC
95. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone
in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-44. DOI PubMed
96. Sasada T, Nakamura H, Ueda S, et al. Possible involvement of thioredoxin reductase as well as thioredoxin in cellular sensitivity to
cis-diamminedichloroplatinum (II). Free Radic Biol Med 1999;27:504-14. DOI PubMed
97. Ishikawa T, Ali-osman F. Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from
leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. J Biol Chem
1993;268:20116-25. PubMed
98. Arnér ES, Nakamura H, Sasada T, Yodoi J, Holmgren A, Spyrou G. Analysis of the inhibition of mammalian thioredoxin,
thioredoxin reductase, and glutaredoxin by cis -diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum
complex. Free Radic Biol Med 2001;31:1170-8. DOI PubMed
99. Zhang X, Zheng Y, Fried LE, et al. Disruption of the mitochondrial thioredoxin system as a cell death mechanism of cationic
triphenylmethanes. Free Radic Biol Med 2011;50:811-20. DOI PubMed PMC
100. Corsello SM, Nagari RT, Spangler RD, et al. Discovering the anti-cancer potential of non-oncology drugs by systematic viability
profiling. Nat Cancer 2020;1:235-48. DOI PubMed PMC
101. Hegde NS, Sanders DA, Rodriguez R, Balasubramanian S. The transcription factor FOXM1 is a cellular target of the natural product
thiostrepton. Nat Chem 2011;3:725-31. DOI PubMed
102. Bhat UG, Halasi M, Gartel AL. FoxM1 is a general target for proteasome inhibitors. PLoS One 2009;4:e6593. DOI PubMed PMC
103. Bird KE, Xander C, Murcia S, et al. Thiopeptides Induce Proteasome-Independent Activation of Cellular Mitophagy. ACS Chem Biol
2020;15:2164-74. DOI PubMed PMC